YI DONG

Dr. YI DONG

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2024 in Science Advances
Verified
Journal Article
Open access
YAYiwei Ai
Yiwei Ai
CGChenxu Guo
Chenxu Guo
MCMarta Garcia Contreras
Marta Garcia Contreras
LBLaura S. Sánchez B.
Laura S. Sánchez B.
ASAndras Saftics
Andras Saftics
SGStephen J. Gould
Stephen J. Gould
Exosomes are secreted vesicles of ~30 to 150 nm diameter that play important roles in human health and disease. To better understand how cells release these vesicles, we examined the biogenesis of the most highly enriched human exosome marker proteins, the exosomal tetraspanins CD81, CD9, and CD63. We show here that endocytosis inhibits their vesicular secretion and, in the case of CD9 and CD81, triggers their destruction. Furthermore, we show that syntenin, a previously described exosome biogenesis factor, drives the vesicular secretion of CD63 by blocking CD63 endocytosis and that other endocytosis inhibitors also induce the plasma membrane accumulation and vesicular secretion of CD63. Finally, we show that CD63 is an expression-dependent inhibitor of endocytosis that triggers the vesicular secretion of lysosomal proteins and the clathrin adaptor AP-2 mu2. These results suggest that the vesicular secretion of exosome marker proteins in exosome-sized vesicles occurs primarily by an endocytosis-independent pathway.

5 April 2024 in Science Advances
Verified
Journal Article
Open access
YDYI DONG
YI DONG
BJBlake A. Johnson
Blake A. Johnson
LRLinhao Ruan
Linhao Ruan
MZMaged Zeineldin
Maged Zeineldin
TBTianhao Bi
Tianhao Bi
RLRong Li
Rong Li
Inflammation-associated fibroblasts (IAFs) are associated with progression and drug resistance of chronic inflammatory diseases such as inflammatory bowel disease (IBD), but their direct impact on epithelial cells is unknown. Here, we developed an in vitro model whereby human colon fibroblasts are induced by specific cytokines and recapitulate key features of IAFs in vivo. When cocultured with patient-derived colon organoids (colonoids), IAFs induced rapid colonoid expansion and barrier disruption due to swelling and rupture of individual epithelial cells. Colonoids cocultured with IAFs also show increased DNA damage, mitotic errors, and proliferation arrest. These IAF-induced epithelial defects are mediated by a paracrine pathway involving prostaglandin E 2 and its receptor EP4, leading to protein kinase A -dependent activation of the cystic fibrosis transmembrane conductance regulator. EP4-specific chemical inhibitors effectively prevented IAF-induced colonoid swelling and restored normal proliferation and genome stability. These findings reveal a mechanism by which IAFs could promote and perpetuate IBD and suggest a therapeutic avenue to mitigate inflammation-associated epithelial injury.

8 November 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
CPChirag H. Patel
Chirag H. Patel
YDYI DONG
YI DONG
NKNavid Koleini
Navid Koleini
XWXiaoxu Wang
Xiaoxu Wang
BDBrittany L. Dunkerly-Eyring
Brittany L. Dunkerly-Eyring
JPJonathan D. Powell
Jonathan D. Powell
MTORC1 integrates signaling from the immune microenvironment to regulate T cell activation, differentiation, and function. TSC2 in the tuberous sclerosis complex tightly regulates mTORC1 activation. CD8 + T cells lacking TSC2 have constitutively enhanced mTORC1 activity and generate robust effector T cells; however, sustained mTORC1 activation prevents generation of long-lived memory CD8 + T cells. Here we show that manipulating TSC2 at Ser1365 potently regulated activated but not basal mTORC1 signaling in CD8 + T cells. Unlike nonstimulated TSC2-KO cells, CD8 + T cells expressing a phosphosilencing mutant TSC2-S1365A (TSC2-SA) retained normal basal mTORC1 activity. PKC and T cell receptor (TCR) stimulation induced TSC2 S1365 phosphorylation, and preventing this with the SA mutation markedly increased mTORC1 activation and T cell effector function. Consequently, SA CD8 + T cells displayed greater effector responses while retaining their capacity to become long-lived memory T cells. SA CD8 + T cells also displayed enhanced effector function under hypoxic and acidic conditions. In murine and human solid-tumor models, SA CD8 + T cells used as adoptive cell therapy displayed greater antitumor immunity than WT CD8 + T cells. These findings reveal an upstream mechanism to regulate mTORC1 activity in T cells. The TSC2-SA mutation enhanced both T cell effector function and long-term persistence/memory formation, supporting an approach to engineer better CAR-T cells for treating cancer.

6 November 2025 in bioRxiv
Verified
Preprint
Open access
ALAlbert Z. Liu
Albert Z. Liu
ANAkshay Narkar
Akshay Narkar
KLKeming Li
Keming Li
TBThierry Bertomeu
Thierry Bertomeu
BJBlake A. Johnson
Blake A. Johnson
RLRong Li
Rong Li
Aneuploidy is a hallmark of cancer and is a potential vulnerability that can be selectively targeted. To systematically identify genes that affect the incidence and fitness of aneuploid cells, we conducted a genome-wide CRISPR/Cas9 screen using NMS-P715, an inhibitor of the spindle assembly checkpoint (SAC) kinase MPS1/TTK. In this study, we identified a number of genes known to regulate aneuploidy and mitosis, and subsequently focused on PRR14L , a ubiquitously expressed gene previously implicated in chronic myelomonocytic leukemia (CMML). Proximity labeling of PRR14L using TurboID revealed several cell division proteins, including the PP2A-B56 phosphatase complex and the spindle assembly factor TACC3, as PRR14L-interacting proteins. Loss of PRR14L prolongs SAC-dependent mitotic arrest in response to microtubule depolymerization but, paradoxically, leads to catastrophic mitotic errors upon SAC abrogation by MPS1 inhibitors. A model derived from our findings provides a rationale for exploiting MPS1 inhibition as a potential vulnerability in cancers containing either PRR14L loss of function mutations or FGFR-TACC3 fusions. Significance Statement: Aneuploidy is a hallmark of cancer. Whether aneuploidy can be selectively targeted is not known. Utilizing a CRISPR/Cas9 screen, the authors found that loss of the gene PRR14L sensitizes cells to aneuploidy induction. Taking advantage of live cell imaging and proximity labeling, they linked PRR14L to TACC3 and mitosis. These findings suggest that spindle checkpoint inhibitors may have therapeutic potential in cancers with either loss-of-function PRR14L and/or gain of function TACC3 mutations.

16 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TBTianhao Bi
Tianhao Bi
VRVaruni Rastogi
Varuni Rastogi
MZMaged Zeineldin
Maged Zeineldin
BJBlake A. Johnson
Blake A. Johnson
YDYI DONG
YI DONG
TLTatianna C. Larman
Tatianna C. Larman
Abnormal nucleolar morphology is a pathognomonic histologic feature of cancer cells. Nucleoli are biomolecular condensates and cytogenetic entities that form around nucleolar organizing regions (NORs), located on the short arms of acrocentric chromosomes. Given that aneuploidy is pervasive in human cancers and can involve NOR-bearing chromosomes, we investigated how aneuploidy-driven changes in NOR dosage impact nucleolar morphology. We used reversine, a spindle assembly checkpoint inhibitor, to induce chromosomal instability and complex aneuploidy in DLD1 colorectal cancer cells (near-euploid) and normal human colon organoids (colonoids, euploid). High resolution 3D imaging and quantitative analyses of reversine-treated cells showed overall doubling of total nucleolar volume per nucleus. Reversine-associated nucleolar enlargement occurred independently of global protein synthesis, and thus was not solely driven by increases in biosynthetic demand. The volume of individual nucleoli showed a direct linear correlation with the number of associated NORs, as revealed by 3D co-localization with NOR-specific FISH probes. These findings establish NOR dosage as a determinant of nucleolar morphology and metric of genomic instability, providing a new paradigm by which aneuploidy can modulate spatial chromosomal constraints and nuclear architecture in cancer. Significance statement: Cancer cells often show enlarged and abnormal nucleoli. We show that aneuploidy, a common feature of cancer, can directly reshape nucleolar morphology by altering the copy number of acrocentric chromosomal regions around which nucleoli form, NORs. Using high-resolution 3D imaging in cell lines and patient-derived colonoids, we find that nucleolar number and volume directly correlate with NOR number, independent of overall protein synthesis. Individual nucleolar volume scales with the number of 3D NOR associations, and prominent single nucleoli arise when NORs accumulate. These results provide evidence that aneuploidy can lead to aberrant nucleolar morphologies seen in many human cancers.